HealthTech

Sohar Health Raises $3.8M for AI-Driven Eligibility Ver...

What You Should Know:  – Sohar Health, an AI-driven provider of eligibility dete...

Tasso Partners with SNBL to Bring Patient-Centric Blood...

What You Should Know:  – Shin Nippon Biomedical Laboratories, Ltd. (SNBL) and Ta...

seca Launches Treatment Tracker: AI-Driven Solution Int...

What You Should Know:  – seca, a global leader in medical measuring and weighing...

J&J wins patent feud against Viatris over schizophrenia...

Johnson & Johnson scored an appeals court win in its bid to block generic compet...

CHMP acts on Opdivo, Tevimbra, Xoanacyl, Kisunla and ot...

Bristol Myers Squibb, BeiGene, AstraZeneca and Pfizer secured European backing f...

Novo Nordisk Lands Lexicon Pharma Obesity Drug With Pot...

Novo Nordisk gets global rights to Lexicon Pharmaceuticals’ LX9851, an oral smal...

Canon’s Vision for Patient-Centered Imaging: Less Stres...

Being patient-centered is very easy to say, but very challenging for a vendor to...

Healthcare March Madness, Botification, and Org Charts ...

Happy Friday everyone!  You made it through another week.  It’s been a crazy wee...

Milestone's shares dive after FDA again rejects drug fo...

Milestone Pharmaceuticals’ nasal spray failed for a second time to secure US app...

Healthcare’s Security Paradox: Most Targeted, Least Pre...

The following is a guest article by Mike Hale, Principal Solutions Engineer at E...

DBV’s financing for peanut allergy patch; Eisai divests...

Plus, news about Palatin, Spero and BioAtla: DBV Technologies’ $306M financi...

European regulator rejects Lilly's Alzheimer’s drug ove...

Eli Lilly’s Alzheimer’s drug Kisunla has failed to get support from the European...

How Community Health Programs are Reducing 911 Calls an...

By focusing on prevention, collaboration, and data-driven innovation, community ...

Bridging the AI Gap in Local Health: Practical Steps fo...

By prioritizing staff education, starting small with practical applications, and...

Leading Global Healthtech Company, Harrison.ai, to Brin...

Company’s Radiology and Pathology Solutions Expand Clinician Capacity, Increase ...

BioNTech details promising mid-stage data for its PD-L1...

BioNTech has highly encouraging survival data for its bispecific antibody combin...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.